Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference16 articles.
1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients;Yusuf;N Engl J Med,2000
2. Telmisartan, ramipril, or both in patients at high risk for vascular events;The ONTARGET Investigators;N Engl J Med,2008
3. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I);Williams;J Hypertens,2006
4. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy;Weber;Rev Cardiovasc Med,2006
5. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease;Kunz;Ann Intern Med,2008